AR035782A1 - Amidas sustituidas de acido benzofuran-2-carboxilico, un procedimiento para su preparacion, las preparaciones farmaceuticas que las contienen y el uso de las mismas para preparar un medicamento - Google Patents
Amidas sustituidas de acido benzofuran-2-carboxilico, un procedimiento para su preparacion, las preparaciones farmaceuticas que las contienen y el uso de las mismas para preparar un medicamentoInfo
- Publication number
- AR035782A1 AR035782A1 ARP020100898A ARP020100898A AR035782A1 AR 035782 A1 AR035782 A1 AR 035782A1 AR P020100898 A ARP020100898 A AR P020100898A AR P020100898 A ARP020100898 A AR P020100898A AR 035782 A1 AR035782 A1 AR 035782A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- hal
- atoms
- group
- coor4
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen amidas sustituidas de ácido benzofuran-2-carboxílico, de fórmula general (1) en la que D es H, OH, OA; CN, Hal, COR3 o CH2R3; R1 es amino, hidroxi, ciano, -C(=NR4)-N(R4)2, Het, cicloalquilo C3-10 insustituido o sustituido por A o alquilo C1-10 lineal o ramificado, con la condición, que al menos un grupo CH2 del grupo alquilo esté sustituido por un átomo de O- ó S-, por grupos CH=CH o por grupos CsC, o con la condición, que al menos un átomo de hidrógeno del grupo alquilo esté sustituido por Hal, OH, Ar, Het, cicloalquilo C3-10, N(R4)2, CN, COOR4, CON(R4)2, NR4COR4, NR4COOR4, NR4CON(R4)2, NR4SO2A o SO2NR4; R2 es H, A o R1, con la condición que cuando R1 significa amino, hidroxi o ciano, R2 es H, o NR1R2 juntos, forman un anillo heterocíclico saturado de 3 a 7 miembros, donde adicionalmente pueden estar presentes 1 o 2 átomos de N- y/o 1 o 2 átomos de S- y/o 1 o 2 átomos de O- y/o un grupo S(O)m, el que puede estar sustituido por A, Hal, cicloalquilo C3-10, OR4, N(R4)2, CN, COOR4, CON(R4)2, NR4COR4 y/o oxicarbonilo; R3 es OH, OA o N(R4)2; R4 es H o A; A es alquilo C1-6 lineal o ramificado, donde por lo menos un grupo CH2 puede estar sustituido por un átomo de O ó S, o por un grupo CH=CH, o al menos un átomo de H puede estar sustituido por F; Ar es fenilo, naftilo o bifenilo insustituido o mono- o polisustituido por Hal, A, OR4, N(R4)2, NO2, CN, COOR4, CON(R4)2, NR4COR4, NR4CON(R4)2, NR4SO2A, COR4, SO2NR4 o S(O)mA; Het es un radical heterocíclico mono- o bicíclico con 5 a 10 miembros, saturado, insaturado o aromático, donde pueden estar presentes 1 a 4 átomos de N- y/o 1 a 4 átomos de S- y/o 1 a 4 átomos de O- y el radical heterocíclico puede estar mono-, di- o trisustituido por Hal, A, -[C(R4)2]o-Ar, -[C(R4)2]o-cicloalquilo, OR4, N(R4)2, NO2, CN, COOR4, CON(R4)2, NR4COA, NR4CON(R4)2, NR4SO2A, COR4, SO2NR4 o S(O)mA y/o oxicarbonilo; Hal es F, Cl, Br o I; n es 2, 3, 4 ó 5; m es 1 ó 2; y o es 1, 2, 3 ó 4, y sus sales y solvatos aceptables para uso fisiológico. Estos compuestos son potentes agonistas de 5-HT1A e inhibidores selectivos de la reabsorción de 5-HT. También se describe un procedimiento para preparar los compuestos de fórmula (1), una preparación farmacéutica que contiene al menos un compuesto de fórmula (1) y el uso de dichos compuestos en la preparación de un medicamento para el tratamiento de depresiones, estados de angustia, ataques de pánico, trastornos obsesivos, enfermedades psiquiátricas, infartos cerebrales, isquemia cerebral, estados de ansiedad, efectos secundarios del tratamiento de la hipertensión sanguínea, para la prevención y el tratamiento de enfermedades cerebrales, acromegalia, hipogonadismo, amenorrea secundaria, síndrome premenstrual, lactancia puerperal no deseada, dolor, trastornos del sueno, narcolepsia, enfermedades bipolares, manías, demencia, enfermedades adictivas, disfunciones sexuales, trastornos de la alimentación, obesidad o fibromialgia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10112151A DE10112151A1 (de) | 2001-03-14 | 2001-03-14 | Substituierte Benzofuran-2-carbonsäureamide |
Publications (1)
Publication Number | Publication Date |
---|---|
AR035782A1 true AR035782A1 (es) | 2004-07-14 |
Family
ID=7677358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020100898A AR035782A1 (es) | 2001-03-14 | 2002-03-13 | Amidas sustituidas de acido benzofuran-2-carboxilico, un procedimiento para su preparacion, las preparaciones farmaceuticas que las contienen y el uso de las mismas para preparar un medicamento |
Country Status (20)
Country | Link |
---|---|
US (1) | US7244846B2 (es) |
EP (1) | EP1368346A1 (es) |
JP (1) | JP4485743B2 (es) |
KR (1) | KR20030080083A (es) |
CN (1) | CN1244578C (es) |
AR (1) | AR035782A1 (es) |
BR (1) | BR0208040A (es) |
CA (1) | CA2440726C (es) |
CZ (1) | CZ20032712A3 (es) |
DE (1) | DE10112151A1 (es) |
EC (1) | ECSP034798A (es) |
EE (1) | EE200300447A (es) |
HU (1) | HUP0303449A3 (es) |
IL (1) | IL157889A0 (es) |
MX (1) | MXPA03008140A (es) |
PL (1) | PL362844A1 (es) |
RU (1) | RU2003129057A (es) |
SK (1) | SK12492003A3 (es) |
WO (1) | WO2002083666A1 (es) |
ZA (1) | ZA200307966B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10259244A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
DE10305739A1 (de) * | 2003-02-11 | 2004-08-19 | Merck Patent Gmbh | Benzofuranderivate |
DE10306941A1 (de) * | 2003-02-18 | 2004-08-26 | Merck Patent Gmbh | Benzofuranoxyethylamine |
DE10326939A1 (de) * | 2003-06-16 | 2005-01-05 | Merck Patent Gmbh | Indol-Derivate |
DE10326940A1 (de) * | 2003-06-16 | 2005-01-05 | Merck Patent Gmbh | Indol-Derivate |
PE20060373A1 (es) | 2004-06-24 | 2006-04-29 | Smithkline Beecham Corp | Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2 |
PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
DE102006060597A1 (de) * | 2006-12-21 | 2008-06-26 | Merck Patent Gmbh | Verfahren zur Herstellung von Benzofuran-2-carboxamiden |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
CA2718138A1 (en) * | 2008-03-14 | 2009-09-17 | Timo Heinrich | Azaindole compounds for treatment of central nervous system disorders |
EP2110374A1 (en) * | 2008-04-18 | 2009-10-21 | Merck Sante | Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ikk2阻害剤としてのインドール誘導体 |
EP2338873A1 (en) | 2009-12-22 | 2011-06-29 | Gmeiner, Peter | New aminotetraline derivatives |
KR101361145B1 (ko) * | 2011-03-10 | 2014-02-12 | 한국화학연구원 | 신규한 벤조퓨란-2-카르복사미드 유도체 및 그의 mch 수용체-1 관련 질환에 대한 치료학적 용도 |
CN103570698B (zh) * | 2012-08-01 | 2016-08-03 | 江苏恩华药业股份有限公司 | 用于制备维拉佐酮的化合物及其中间体和应用 |
EP3027607B1 (en) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
DE19730989A1 (de) * | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
TW518218B (en) | 1999-05-27 | 2003-01-21 | Merck Patent Gmbh | Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders |
-
2001
- 2001-03-14 DE DE10112151A patent/DE10112151A1/de not_active Withdrawn
-
2002
- 2002-02-27 CZ CZ20032712A patent/CZ20032712A3/cs unknown
- 2002-02-27 CN CNB028058135A patent/CN1244578C/zh not_active Expired - Fee Related
- 2002-02-27 CA CA2440726A patent/CA2440726C/en not_active Expired - Fee Related
- 2002-02-27 SK SK1249-2003A patent/SK12492003A3/sk not_active Application Discontinuation
- 2002-02-27 IL IL15788902A patent/IL157889A0/xx unknown
- 2002-02-27 KR KR10-2003-7011886A patent/KR20030080083A/ko not_active Application Discontinuation
- 2002-02-27 EE EEP200300447A patent/EE200300447A/xx unknown
- 2002-02-27 WO PCT/EP2002/002093 patent/WO2002083666A1/en active IP Right Grant
- 2002-02-27 RU RU2003129057/04A patent/RU2003129057A/ru not_active Application Discontinuation
- 2002-02-27 PL PL02362844A patent/PL362844A1/xx unknown
- 2002-02-27 US US10/471,584 patent/US7244846B2/en not_active Expired - Fee Related
- 2002-02-27 EP EP02729940A patent/EP1368346A1/en not_active Withdrawn
- 2002-02-27 MX MXPA03008140A patent/MXPA03008140A/es unknown
- 2002-02-27 BR BR0208040-0A patent/BR0208040A/pt not_active IP Right Cessation
- 2002-02-27 JP JP2002581421A patent/JP4485743B2/ja not_active Expired - Fee Related
- 2002-02-27 HU HU0303449A patent/HUP0303449A3/hu unknown
- 2002-03-13 AR ARP020100898A patent/AR035782A1/es not_active Application Discontinuation
-
2003
- 2003-10-09 EC EC2003004798A patent/ECSP034798A/es unknown
- 2003-10-13 ZA ZA200307966A patent/ZA200307966B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20032712A3 (cs) | 2004-01-14 |
JP2004527536A (ja) | 2004-09-09 |
RU2003129057A (ru) | 2005-04-10 |
HUP0303449A2 (hu) | 2004-01-28 |
CN1244578C (zh) | 2006-03-08 |
PL362844A1 (en) | 2004-11-02 |
EE200300447A (et) | 2003-12-15 |
JP4485743B2 (ja) | 2010-06-23 |
BR0208040A (pt) | 2004-02-25 |
US20050075269A1 (en) | 2005-04-07 |
US7244846B2 (en) | 2007-07-17 |
CA2440726C (en) | 2011-05-17 |
MXPA03008140A (es) | 2003-12-12 |
SK12492003A3 (sk) | 2004-03-02 |
ECSP034798A (es) | 2003-12-01 |
EP1368346A1 (en) | 2003-12-10 |
HUP0303449A3 (en) | 2005-02-28 |
ZA200307966B (en) | 2005-01-13 |
DE10112151A1 (de) | 2002-09-19 |
WO2002083666A1 (en) | 2002-10-24 |
KR20030080083A (ko) | 2003-10-10 |
CN1494543A (zh) | 2004-05-05 |
CA2440726A1 (en) | 2002-10-24 |
IL157889A0 (en) | 2004-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR035782A1 (es) | Amidas sustituidas de acido benzofuran-2-carboxilico, un procedimiento para su preparacion, las preparaciones farmaceuticas que las contienen y el uso de las mismas para preparar un medicamento | |
AR119731A1 (es) | Inhibidores del inflamasoma nlrp3 | |
EP3337481A1 (en) | Human tlr8-selective agonists | |
AR052269A1 (es) | Analogos de rapamicina, un proceso para su elaboracion y los usos de los mismos en la preparacion de un medicamento para el tratamiento de trastornos neurologicos, proliferativos e inflamatorios. | |
PE20060689A1 (es) | Derivados de sulfonamidas como antagonistas de receptores orexina 2 | |
HRP20110400T1 (hr) | Derivati 2-(1h-indolilsulfanil)-benzil amina kao ssri | |
ECSP056164A (es) | Compuestos utiles para el tratamiento de enfermedades | |
UY28724A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
BRPI0615663A2 (pt) | derivados de amida e carbamato de n - [4 - (4-amino-1h-imidazo [4,5-c] quinolin-1il) butil] metanossulfonamidas substituìdas com alquila, composição farmacêutica destes e seus usos | |
AR036103A1 (es) | Imidazotriazinas, procedimiento para su preparacion, uso de dichos compuestos para la manufactura de un medicamento para enfermedades neurodegenerativas y dicho medicamento | |
ES2170732B2 (es) | Procedimiento para preparar citalopram purificado | |
RU2001123126A (ru) | Производные пиридопираноазепинов, их получение и терапевтическое применение | |
AR049577A1 (es) | Derivados de hidantoina, procesos para su preparacion, composiciones y su uso | |
AR031867A1 (es) | Compuestos derivados de fenoxibencilamina como ssri, su uso en la preparacion de medicamentos, procedimiento de preparacion del compuesto e intermediarios utiles | |
JP7251893B2 (ja) | N-1分枝基を有する置換イミダゾ[4,5-c]キノリン化合物 | |
AR046086A1 (es) | Derivados de 1,3- benzoxazolilo como inhibidores de quinasa | |
AR127050A1 (es) | Compuestos espirocíclicos | |
AR044666A1 (es) | Derivados benzoimidazolicos, composiciones que los contienen, su preparacion y usos de los mismos. | |
AR035083A1 (es) | Derivados azaheterociclilmetilicos de 7,8-dihidro-6h-5-oxa-1-aza-fenantreno, composiciones farmaceuticas, el uso de dichos derivados para la preparacion de un medicamento antidepresivo e intermediarios | |
AR037507A1 (es) | Derivados de acido acetico sustituidos, un procedimiento para su preparacion, medicamentos, un procedimiento para su preparacion, el uso de dichos compuestos para la preparacion de medicamentos | |
AR036166A1 (es) | Compuestos de octahidro-2h-pirido[1,2-a]piracina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
AR063924A1 (es) | Analogos de pirazol | |
AR034861A1 (es) | Un compuesto de indenoindolona, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende | |
AR008245A1 (es) | Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados | |
AR041026A1 (es) | Derivados de aril- y heteroarilmorfolina, su uso en la preparacion de un medicamento y composicion farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |